255 related articles for article (PubMed ID: 24604900)
1. NAP1 strain type predicts outcomes from Clostridium difficile infection.
See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
[TBL] [Abstract][Full Text] [Related]
2. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
3. The evolving epidemiology of
Katz KC; Golding GR; Choi KB; Pelude L; Amaratunga KR; Taljaard M; Alexandre S; Collet JC; Davis I; Du T; Evans GA; Frenette C; Gravel D; Hota S; Kibsey P; Langley JM; Lee BE; Lemieux C; Longtin Y; Mertz D; Mieusement LMD; Minion J; Moore DL; Mulvey MR; Richardson S; Science M; Simor AE; Stagg P; Suh KN; Taylor G; Wong A; Thampi N;
CMAJ; 2018 Jun; 190(25):E758-E765. PubMed ID: 29941432
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
[TBL] [Abstract][Full Text] [Related]
5. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
[TBL] [Abstract][Full Text] [Related]
7. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
8. Comparison of strain typing results for Clostridium difficile isolates from North America.
Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S
Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.
Cloud J; Noddin L; Pressman A; Hu M; Kelly C
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):868-873.e2. PubMed ID: 19465153
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
14. A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult.
Heslop OD; Roye-Green K; Coard K; Mulvey MR
BMC Infect Dis; 2013 Jul; 13():299. PubMed ID: 23815405
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
[TBL] [Abstract][Full Text] [Related]
16. Burden of Clostridium difficile infection in the United States.
Lessa FC; Mu Y; Bamberg WM; Beldavs ZG; Dumyati GK; Dunn JR; Farley MM; Holzbauer SM; Meek JI; Phipps EC; Wilson LE; Winston LG; Cohen JA; Limbago BM; Fridkin SK; Gerding DN; McDonald LC
N Engl J Med; 2015 Feb; 372(9):825-34. PubMed ID: 25714160
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection in children hospitalized due to diarrhea.
Dulęba K; Pawłowska M; Wietlicka-Piszcz M
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):201-9. PubMed ID: 24213847
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis.
Vardakas KZ; Konstantelias AA; Loizidis G; Rafailidis PI; Falagas ME
Int J Infect Dis; 2012 Nov; 16(11):e768-73. PubMed ID: 22921930
[TBL] [Abstract][Full Text] [Related]
19. Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.
Forgetta V; Oughton MT; Marquis P; Brukner I; Blanchette R; Haub K; Magrini V; Mardis ER; Gerding DN; Loo VG; Miller MA; Mulvey MR; Rupnik M; Dascal A; Dewar K
J Clin Microbiol; 2011 Jun; 49(6):2230-8. PubMed ID: 21508155
[TBL] [Abstract][Full Text] [Related]
20. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
